Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Discovery of recurrent structural variants in nasopharyngeal carcinoma.

Valouev A, Weng Z, Sweeney RT, Varma S, Le QT, Kong C, Sidow A, West RB.

Genome Res. 2014 Feb;24(2):300-9. doi: 10.1101/gr.156224.113. Epub 2013 Nov 8.

2.

Clinicopathological significance of MAML2 gene split in mucoepidermoid carcinoma.

Noda H, Okumura Y, Nakayama T, Miyabe S, Fujiyoshi Y, Hattori H, Shimozato K, Inagaki H.

Cancer Sci. 2013 Jan;104(1):85-92. doi: 10.1111/cas.12039. Epub 2012 Nov 8.

3.

[Differentially expressed transcription factor-related genes in nasopharyngeal carcinoma and nasopharyngeal tissues].

Wang S, Lu LC, Fang WY, Yao KT.

Nan Fang Yi Ke Da Xue Xue Bao. 2007 Feb;27(2):146-9. Chinese.

4.

CRTC1 rearrangements in the absence of t(11;19) in primary cutaneous mucoepidermoid carcinoma.

Lennerz JK, Perry A, Dehner LP, Pfeifer JD, Lind AC.

Br J Dermatol. 2009 Oct;161(4):925-9. doi: 10.1111/j.1365-2133.2009.09200.x. Epub 2009 Apr 29.

PMID:
19438452
5.

Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma.

Nakayama T, Miyabe S, Okabe M, Sakuma H, Ijichi K, Hasegawa Y, Nagatsuka H, Shimozato K, Inagaki H.

Mod Pathol. 2009 Dec;22(12):1575-81. doi: 10.1038/modpathol.2009.126. Epub 2009 Sep 11.

6.

CRTC1-MAML2 and CRTC3-MAML2 fusions were not detected in metaplastic Warthin tumor and metaplastic pleomorphic adenoma of salivary glands.

Skálová A, Vanecek T, Simpson RH, Vazmitsel MA, Majewska H, Mukensnabl P, Hauer L, Andrle P, Hosticka L, Grossmann P, Michal M.

Am J Surg Pathol. 2013 Nov;37(11):1743-50. doi: 10.1097/PAS.0000000000000065.

PMID:
24121173
7.

A new type of MAML2 fusion in mucoepidermoid carcinoma.

Fehr A, Röser K, Heidorn K, Hallas C, Löning T, Bullerdiek J.

Genes Chromosomes Cancer. 2008 Mar;47(3):203-6.

PMID:
18050304
8.

Genomic profiles and CRTC1-MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma.

Jee KJ, Persson M, Heikinheimo K, Passador-Santos F, Aro K, Knuutila S, Odell EW, Mäkitie A, Sundelin K, Stenman G, Leivo I.

Mod Pathol. 2013 Feb;26(2):213-22. doi: 10.1038/modpathol.2012.154. Epub 2012 Sep 28.

9.

Fluorescence in-situ hybridization identifies Mastermind-like 2 (MAML2) rearrangement in odontogenic cysts with mucous prosoplasia: a pilot study.

Argyris PP, Wehrs RN, García JJ, Koutlas IG.

Histopathology. 2015 May;66(6):791-7. doi: 10.1111/his.12526. Epub 2015 Jan 23.

PMID:
25123064
10.

Identification of candidate molecular markers of nasopharyngeal carcinoma by microarray analysis of subtracted cDNA libraries constructed by suppression subtractive hybridization.

Zhou Y, Zeng Z, Zhang W, Xiong W, Li X, Zhang B, Yi W, Xiao L, Wu M, Shen S, Li X, Cao L, Tang K, Li G.

Eur J Cancer Prev. 2008 Nov;17(6):561-71. doi: 10.1097/CEJ.0b013e328305a0e8.

PMID:
18941378
11.

Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.

von Holstein SL, Fehr A, Persson M, Nickelsen M, Therkildsen MH, Prause JU, Heegaard S, Stenman G.

Ophthalmology. 2014 May;121(5):1125-33. doi: 10.1016/j.ophtha.2013.11.037. Epub 2014 Jan 24.

PMID:
24468654
12.

HER2 and EGFR gene copy number alterations are predominant in high-grade salivary mucoepidermoid carcinoma irrespective of MAML2 fusion status.

Nakano T, Yamamoto H, Hashimoto K, Tamiya S, Shiratsuchi H, Nakashima T, Nishiyama K, Higaki Y, Komune S, Oda Y.

Histopathology. 2013 Sep;63(3):378-92. doi: 10.1111/his.12183. Epub 2013 Jul 16.

PMID:
23855785
13.

Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma.

Or YY, Chung GT, To KF, Chow C, Choy KW, Tong CY, Leung AW, Hui AB, Tsao SW, Ng HK, Yip TT, Busson P, Lo KW.

J Pathol. 2010 Jan;220(1):97-107. doi: 10.1002/path.2609.

PMID:
19718711
14.

Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma.

Achcar Rde O, Nikiforova MN, Dacic S, Nicholson AG, Yousem SA.

Hum Pathol. 2009 Jun;40(6):854-60. doi: 10.1016/j.humpath.2008.11.007. Epub 2009 Mar 9.

PMID:
19269006
15.

t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma.

O'Neill ID.

Oral Oncol. 2009 Jan;45(1):2-9. doi: 10.1016/j.oraloncology.2008.03.012. Epub 2008 May 16. Review.

PMID:
18486532
16.

Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.

Tong JH, Ng DC, Chau SL, So KK, Leung PP, Lee TL, Lung RW, Chan MW, Chan AW, Lo KW, To KF.

BMC Cancer. 2010 Jun 3;10:253. doi: 10.1186/1471-2407-10-253.

17.

The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas.

Chan SL, Cui Y, van Hasselt A, Li H, Srivastava G, Jin H, Ng KM, Wang Y, Lee KY, Tsao GS, Zhong S, Robertson KD, Rha SY, Chan AT, Tao Q.

Lab Invest. 2007 Jul;87(7):644-50. Epub 2007 Mar 26.

18.

Thymic Mucoepidermoid Carcinoma: Report of a Case With CTRC1/3-MALM2 Molecular Studies.

Prieto-Granada CN, Inagaki H, Mueller J.

Int J Surg Pathol. 2015 Jun;23(4):277-83. doi: 10.1177/1066896915576959. Epub 2015 Mar 17.

PMID:
25782731
19.

The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.

Ladanyi M, Lui MY, Antonescu CR, Krause-Boehm A, Meindl A, Argani P, Healey JH, Ueda T, Yoshikawa H, Meloni-Ehrig A, Sorensen PH, Mertens F, Mandahl N, van den Berghe H, Sciot R, Dal Cin P, Bridge J.

Oncogene. 2001 Jan 4;20(1):48-57.

20.

[Gene expression profiles in different tissues of human nasopharyngeal carcinoma].

Han HX, Yao LS, Wang S, Han WN, Yao KT.

Di Yi Jun Yi Da Xue Xue Bao. 2004 Oct;24(10):1126-9. Chinese.

Supplemental Content

Support Center